Gilead and MSD Pharmaceuticals Collaborate on Dual HIV Treatment
The pharmaceutical companies Gilead and MSD (known as Merck in the US and Canada) announced this Monday that they will collaborate in the investigation of a long-term treatment for people with HIV that combines experimental drugs of both in advanced clinical phases. Pharmaceutical rivals are seeking to develop and commercialize a “two-drug regimen with the […]
Continue Reading